Keeping CRISPR in Check | The Scientist Magazine® – The Scientist
The Scientist |
Keeping CRISPR in Check | The Scientist Magazine®
The Scientist In bacteriophage genomes, researchers find three anti-CRISPR proteins that naturally inhibit CRISPR-Cas9 in one bacterial species and can do the same in … New CRISPR ‘Off-Switch’ Provides Greater Control on Gene Editing …Nature World News |
Phys.Org |
Researchers turn back the clock on human embryonic stem cells
Phys.Org The investigators say the ability to reset the stem cells‘ developmental clock to an earlier stage offers new opportunities to successfully coax human stem cells into making any kind of cell on demand for use as transplants and in genetic disease modeling. |
|
VistaGen Therapeutics Grants Exclusive Sublicense of Cardiac Stem Cell Technologies to BlueRock Therapeutics
Yahoo Finance VistaGen licensed exclusive rights of the cardiac stem cell technologies from University Health Network (UHN), Canada’s largest research hospital, pursuant to a strategic research agreement with UHN and distinguished UHN researcher, Dr. Gordon Keller, … Bayer And Versant’s Big Bet On Stem CellsSeeking Alpha |
|
VistaGen Therapeutics Grants Exclusive Sublicense of Cardiac Stem Cell Technologies to BlueRock Therapeutics
PR Newswire (press release) VistaGen licensed exclusive rights of the cardiac stem cell technologies from University Health Network (UHN), Canada’s largest research hospital, pursuant to a strategic research agreement with UHN and distinguished UHN researcher, Dr. Gordon Keller, … VistaGen sublicenses rights to stem cell-related technologies to Bayer-backed research firm; shares up 5% premarketSeeking Alpha |